Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:12 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $39.0M (26.1% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Revenue | $149.2M | $74.9M | $71.3M | $65.2M | $55.3M |
| Cost of revenue | $76.8M | $20.7M | $19.6M | $15.5M | $11.7M |
| Gross profit | $72.3M | $54.2M | $51.7M | $49.7M | $43.7M |
| Operating expenses | $103.7M | $88.7M | $82.3M | $84.8M | $71.2M |
| Research and development | $6.58M | $12.8M | $9.52M | $9.34M | $7.92M |
| Selling, general and administrative | $49.7M | $30.3M | $25.4M | $25.5M | $25.6M |
| Operating income | -$31.4M | -$34.6M | -$30.6M | -$35.1M | -$27.6M |
| Interest expense | $7.60M | $7.29M | $5.42M | $4.25M | $4.02M |
| Net income | -$39.0M | -$43.7M | -$30.2M | -$37.2M | -$31.2M |
| EPS, basic | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 |
| EPS, diluted | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 |
| Weighted shares, basic | 66.0M | 31.7M | 28.7M | 26.9M | 25.5M |
| Weighted shares, diluted | 66.0M | 31.7M | 28.7M | 26.9M | 25.5M |
| Margins and growth | |||||
| Gross margin | 48.5% | 72.3% | 72.5% | 76.3% | 78.9% |
| Operating margin | -21.1% | -46.2% | -42.8% | -53.8% | -49.8% |
| Net margin | -26.1% | -58.4% | -42.3% | -57.0% | -56.4% |
| Revenue growth, year over year | +99.2% | +5.0% | +9.4% | +17.9% | +12.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Cash and equivalents | $28.1M | $18.5M | $59.7M | $70.3M | $94.1M |
| Accounts receivable | $16.5M | $23.4M | $15.8M | $13.6M | $7.71M |
| Inventory | $4.33M | $4.25M | $8.09M | $8.90M | $6.56M |
| Total current assets | $61.6M | $58.1M | $93.8M | $98.8M | $115.3M |
| Property, plant and equipment | $4.47M | $6.24M | $2.01M | $1.99M | $1.22M |
| Goodwill | $23.6M | $18.6M | – | – | – |
| Intangible assets | $18.1M | $19.6M | – | – | – |
| Total assets | $141.6M | $140.9M | $115.8M | $116.9M | $141.2M |
| Accounts payable | $10.7M | $11.1M | $4.75M | $2.43M | $4.30M |
| Short-term debt | – | – | – | $13.1M | – |
| Total current liabilities | $30.5M | $31.3M | $19.8M | $33.2M | $15.7M |
| Long-term debt | $65.8M | $55.2M | $59.3M | $22.8M | $35.3M |
| Total liabilities | $115.3M | $109.1M | $81.6M | $59.8M | $56.0M |
| Shareholders' equity | $26.2M | $31.8M | $34.2M | $57.1M | $85.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 10, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Jan 10, 2022 |
| Operating cash flow | -$20.4M | -$31.0M | -$32.0M | -$30.7M | -$28.0M |
| Capital expenditures | $801.0K | $1.47M | $2.37M | $3.27M | $2.35M |
| Free cash flow | -$21.2M | -$32.5M | -$34.4M | -$34.0M | -$30.3M |
| Depreciation and amortization | $3.46M | $2.07M | $2.01M | $1.65M | $1.06M |
| Stock-based compensation | $6.85M | $5.60M | $7.32M | $8.75M | $7.87M |
| Investing cash flow | -$801.0K | -$2.41M | -$1.32M | $6.73M | -$9.84M |
| Financing cash flow | $35.9M | -$6.81M | $22.7M | $207.0K | $83.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 4.6% | 7.5% | 10.3% | 13.4% | 14.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 28, 2026 | 77.7M | +13.5% | SEC |
| Aug 5, 2026 | 76.2M | +15.2% | SEC |
| May 1, 2026 | 69.6M | +5.7% | SEC |
| Mar 10, 2026 | 69.3M | +5.3% | SEC |
| Oct 29, 2025 | 68.5M | +125.7% | SEC |
| Jul 31, 2025 | 66.1M | +118.3% | SEC |
| May 1, 2025 | 65.8M | +119.4% | SEC |
| Mar 18, 2025 | 65.8M | +121.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.